Cargando…

Development and application of hyaluronic acid in tumor targeting drug delivery

Hyaluronic acid (HA) is a natural polysaccharide that has gained much attention due to its biocompatibility, enzyme degradation capacity and active tumor targeting capacity. Its receptor, CD44, is overexpressed in many kinds of cancers and is associated with tumor progress, infiltration and metastas...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Zhijian, Dai, Yan, Gao, Huile
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900560/
https://www.ncbi.nlm.nih.gov/pubmed/31867159
http://dx.doi.org/10.1016/j.apsb.2019.06.004
_version_ 1783477372768485376
author Luo, Zhijian
Dai, Yan
Gao, Huile
author_facet Luo, Zhijian
Dai, Yan
Gao, Huile
author_sort Luo, Zhijian
collection PubMed
description Hyaluronic acid (HA) is a natural polysaccharide that has gained much attention due to its biocompatibility, enzyme degradation capacity and active tumor targeting capacity. Its receptor, CD44, is overexpressed in many kinds of cancers and is associated with tumor progress, infiltration and metastasis. Therefore, many researchers have developed various HA-based drug delivery systems for CD44-mediated tumor targeting. In this review, we systemically overview the basic theory of HA, its receptor and hyaluronidase, then we categorize the studies in HA-based drug delivery systems according to the functions of HA, including tumor-targeting materials, enzyme-sensitive biodegradable modality, pH-sensitive component, reduction-sensitive component, and the gel backbone. Finally, the perspective is discussed.
format Online
Article
Text
id pubmed-6900560
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-69005602019-12-20 Development and application of hyaluronic acid in tumor targeting drug delivery Luo, Zhijian Dai, Yan Gao, Huile Acta Pharm Sin B Review Hyaluronic acid (HA) is a natural polysaccharide that has gained much attention due to its biocompatibility, enzyme degradation capacity and active tumor targeting capacity. Its receptor, CD44, is overexpressed in many kinds of cancers and is associated with tumor progress, infiltration and metastasis. Therefore, many researchers have developed various HA-based drug delivery systems for CD44-mediated tumor targeting. In this review, we systemically overview the basic theory of HA, its receptor and hyaluronidase, then we categorize the studies in HA-based drug delivery systems according to the functions of HA, including tumor-targeting materials, enzyme-sensitive biodegradable modality, pH-sensitive component, reduction-sensitive component, and the gel backbone. Finally, the perspective is discussed. Elsevier 2019-11 2019-06-20 /pmc/articles/PMC6900560/ /pubmed/31867159 http://dx.doi.org/10.1016/j.apsb.2019.06.004 Text en © 2019 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review
Luo, Zhijian
Dai, Yan
Gao, Huile
Development and application of hyaluronic acid in tumor targeting drug delivery
title Development and application of hyaluronic acid in tumor targeting drug delivery
title_full Development and application of hyaluronic acid in tumor targeting drug delivery
title_fullStr Development and application of hyaluronic acid in tumor targeting drug delivery
title_full_unstemmed Development and application of hyaluronic acid in tumor targeting drug delivery
title_short Development and application of hyaluronic acid in tumor targeting drug delivery
title_sort development and application of hyaluronic acid in tumor targeting drug delivery
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900560/
https://www.ncbi.nlm.nih.gov/pubmed/31867159
http://dx.doi.org/10.1016/j.apsb.2019.06.004
work_keys_str_mv AT luozhijian developmentandapplicationofhyaluronicacidintumortargetingdrugdelivery
AT daiyan developmentandapplicationofhyaluronicacidintumortargetingdrugdelivery
AT gaohuile developmentandapplicationofhyaluronicacidintumortargetingdrugdelivery